Nowinski R, Berglund C, Lane J, Lostrom M, Bernstein I, Young W, Hakomori S I, Hill L, Cooney M
Science. 1980 Oct 31;210(4469):537-9. doi: 10.1126/science.7423202.
Hybrid cells formed between human lymphocytes and mouse myeloma cells produce human immunoglobulin in culture. Stable antibody-producing cell lines can be isolated after multiple cycles of low-density passage, cloning, and continued selection for immunoglobulin production. The origin and characteristics of a hybrid of human and mouse cells is described. This hybrid produces high concentrations (8.3 micrograms per milliliter) of human immunoglobulin M reactive with the terminal disaccharide of the Forssman glycolipid. These findings point to the potential use of human-mouse hybrid cells as a source of human monoclonal antibodies for therapeutic and diagnostic purposes.
人淋巴细胞与小鼠骨髓瘤细胞形成的杂交细胞在培养中产生人免疫球蛋白。经过多次低密度传代、克隆以及持续筛选免疫球蛋白产生细胞后,可分离出稳定的抗体产生细胞系。本文描述了人鼠杂交细胞的起源和特性。这种杂交细胞产生高浓度(每毫升8.3微克)与人福斯曼糖脂末端二糖反应的人免疫球蛋白M。这些发现表明人鼠杂交细胞有潜力作为治疗和诊断用途的人单克隆抗体来源。